These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9388047)

  • 1. The effects of long-term treatment on left ventricular hypertrophy in patients with essential hypertension: relation to changes in neurohumoral factors.
    Ueno H; Takata M; Tomita S; Oh-hashi S; Yasumoto K; Inoue H
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):643-8. PubMed ID: 9388047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effects of temocapril and cadralazine on electrocardiographic voltages and left ventricular mass in patients with essential hypertension.
    Tomita S; Takata M; Yasumoto K; Tomoda F; Ueno H; Inoue H
    Jpn Heart J; 1999 Jan; 40(1):55-63. PubMed ID: 10370397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
    Takami T; Shigematsu M
    Clin Exp Hypertens; 2003 Nov; 25(8):525-35. PubMed ID: 14649310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system.
    du Cailar G; Fesler P; Ribstein J; Mimran A
    Hypertension; 2010 Nov; 56(5):865-70. PubMed ID: 20921428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
    Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
    Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
    Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
    Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
    Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.
    Muscholl MW; Schunkert H; Muders F; Elsner D; Kuch B; Hense HW; Riegger GA
    Am Heart J; 1998 Jan; 135(1):58-66. PubMed ID: 9453522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.
    Devereux RB; Palmieri V; Sharpe N; De Quattro V; Bella JN; de Simone G; Walker JF; Hahn RT; Dahlöf B
    Circulation; 2001 Sep; 104(11):1248-54. PubMed ID: 11551875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
    Kohno M; Horio T; Yokokawa K; Yasunari K; Ikeda M; Minami M; Kurihara N; Takeda T
    Am J Med; 1995 Mar; 98(3):257-65. PubMed ID: 7872342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effects of rilmenidine on left ventricular hypertrophy and systolic and diastolic function in patients with essential hypertension: comparison with an angiotensin converting enzyme inhibitor and a calcium antagonist.
    Koldas L; Ayan F; Ikitimur B
    Jpn Heart J; 2003 Sep; 44(5):693-704. PubMed ID: 14587651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temocapril prevents transition to diastolic heart failure in rats even if initiated after appearance of LV hypertrophy and diastolic dysfunction.
    Sakata Y; Yamamoto K; Mano T; Nishikawa N; Yoshida J; Miwa T; Hori M; Masuyama T
    Cardiovasc Res; 2003 Mar; 57(3):757-65. PubMed ID: 12618237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory blood pressure and left ventricular changes during antihypertensive treatment: perindopril versus isradipine.
    Grandi AM; Bignotti M; Gaudio G; Zanzi P; Guasti L; Venco A
    J Cardiovasc Pharmacol; 1995 Nov; 26(5):737-41. PubMed ID: 8637188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of antihypertensive treatment in elderly hypertensive patients with cardiac hypertrophy].
    Nagano N; Nagano M; Iwatsubo H; Hata T; Mikami H; Ogihara T
    Nihon Ronen Igakkai Zasshi; 1992 Jun; 29(6):457-62. PubMed ID: 1388212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension.
    Diamond JA; Krakoff LR; Goldman A; Coplan N; Gharavi A; Martin K; Goldsmith R; Henzlova MJ; Machac J; Phillips RA
    Am J Hypertens; 2001 Mar; 14(3):231-40. PubMed ID: 11281234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypertension with perindopril reduces plasma atrial natriuretic peptide levels, left ventricular mass, and improves echocardiographic parameters of diastolic function.
    Yalçin F; Aksoy FG; Muderrisoglu H; Sabah I; Garcia MJ; Thomas JD
    Clin Cardiol; 2000 Jun; 23(6):437-41. PubMed ID: 10875035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
    Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
    J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of different antihypertensive drugs on left ventricular hypertrophy in a population sample of elderly men.
    Andrén B; Lind L; Lithell H
    J Hum Hypertens; 1999 Aug; 13(8):499-504. PubMed ID: 10455469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.